Hyperhomocysteinemia Is a Risk Factor for Alzheimer's Disease in an Algerian Population

Archives of Medical Research

Volumn 45, Issue 3, 2014, Pages 247-250

  Nazef, Khaled ^a   Khelil, Malika ^a   Chelouti, Hiba ^a   Kacimi, Ghouti ^b   Bendini, Mohamed ^b   Tazir, Meriem ^c   Belarbi, Soraya ^c   El Hadi Cherifi, Mohamed ^d   Djerdjouri, Bahia ^a  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b Hopital Central de l'Armee   (Algeria)

^c CHU Mustapha   (Algeria)

^d Parnet Hospital   (Algeria)

Author keywords

Alzheimer's disease; Folate; Hyperhomocysteinemia; Vitamin B12

Indexed keywords

CHOLESTEROL; CREATININE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; THYROTROPIN; UREA; URIC ACID;

AGED; ALGERIA; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; MINI MENTAL STATE EXAMINATION; PREDICTOR VARIABLE; RISK FACTOR; UREA BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ALZHEIMER'S DISEASE; FOLATE; HYPERHOMOCYSTEINEMIA; VITAMIN B12;

AGED; AGED, 80 AND OVER; ALGERIA; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CHOLESTEROL; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LOGISTIC MODELS; MALE; RISK FACTORS; THYROTROPIN; URIC ACID; VITAMIN B 12; VITAMIN B 12 DEFICIENCY; VITAMIN B COMPLEX;

EID: 84899537062     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2014.03.001     Document Type: Article

References (30)

1. Forstl H., Kurz A. Clinical features of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 1999, 249:288-290.
2. Jellinger K. Morphology of Alzheimer's disease and related disorders. Alzheimer's Disease: Epidemiology, Neuropathology, Neurochemistry, and Clinics 1990, 61-77. Springer-Verlag, Berlin. K. Maurer, P. Riederer, H. Beckmann (Eds.).
3. Selkoe D.J. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 1997, 275:630-631.
4. Clarke R., Smith A.D., Jobst K.A., et al. Folate, vitamin B 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998, 55:1449-1455.
5. Cascalheira J.F., João S.S., Pinhanços S.S., et al. Serum homocysteine: interplay with other circulating and genetic factors in association to Alzheimer's type dementia. Clin Biochem 2009, 42:783-790.
6. Hooshmand B., Solomon A., Kåreholt I., et al. Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study. Neurology 2010, 75:1408-1414.
7. Seshadri S., Beiser A., Selhub J., et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002, 346:476-483.
8. Mattson M.P., Shea T.B. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 2003, 26:137-146.
9. Köseoglu E., Karaman Y. Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease. Clin Biochem 2007, 40:859-863.
10. Quadri P., Fragicomo C., Pezzati R., et al. Homocysteine, folate and vitaminB-12 in mild cognitive impairment, Alzheimer disease and vascular dementia. Am J Clin Nutr 2004, 80:114-122.
11. Selhub J., Jacques P.F., Wilson P.W., et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993, 270:2693-2698.
12. Ho P.I., Ashline D., Dhitavat S., et al. Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiol Dis 2003, 14:32-42.
13. Zhuo J.M., Praticò D. Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet. Exp Gerontol 2010, 45:195-201.
14. Preux P.M., Odermatt P., Perna A., et al. Qu'est-ce qu'une régression logistique?. Rev Mal Respir 2005, 22:159-162.
15. Houcher B., Candito M., Gibelin P., et al. Assessment of folate status: measurement of homocysteine versus vitamin B12 and folate. Pteridines 2003, 14:27-33.
16. Ravaglia G., Forti P., Maioli F., et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 2005, 82:636-643.
17. Selley M.L., Close D.R., Stern S.E. The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging 2002, 23:383-388.
18. Agnati L.F., Genedani S., Rasio G., et al. Studies on homocysteine plasma levels in Alzheimer's patients. Relevance for neurodegeneration. J Neural Transm 2005, 112:163-169.
19. Loscalzo J. The oxidant stress of hyperhomocysteinemia. J Clin Invest 1996, 98:5-7.
20. Morillas-Ruiz J.M., Rubio-Perez J.M., Albaladejo M.D., et al. Effect of anantioxidant drink on homocysteine levels in Alzheimer's patients. J Neurol Sci 2010, 299:175-178.
21. Vafai S.B., Stock J.B. Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's Disease. FEBS Lett 2002, 518:1-4.
22. Zhang C.E., Tian Q., Wei W., et al. Homocysteine induces tau phosphorylation by inactivating protein. Neurobiol Aging 2008, 29:1654-1665.
23. Smith J.S., Kiloh L.G. The investigation of dementia: results in 200 consecutive admissions. Lancet 1981, 1:824-827.
24. Cummings J., Benson D.F., LoVerme S. Reversible dementia: illustrative cases, definition, and review. JAMA 1980, 243:2434-2439.
25. Shore D., Henkin R.I., Nelson N.R., et al. Hair and serum copper, zinc, calcium, and magnesium concentrations in Alzheimer-type dementia. J Am Geriatr Soc 1984, 32:892-895.
26. Notkola I.L., Sulkava R., Pekkanen J., et al. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 1998, 17:14-20.
27. Kuo Y.M., Emmerling M.R., Bisgaier C.L., et al. Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochem Biophys Res Commun 1998, 252:711-715.
28. Sjögren M., Mielke M., Gustafson D., et al. Cholesterol and Alzheimer's disease-is there a relation?. Mech Ageing Dev 2006, 127:138-147.
29. Wolf H., Hensel A., Arendt T., et al. Serum lipids and hippocampal volume: the link to Alzheimer's disease?. Ann Neurol 2004, 56:745-748.
30. Reiss A. Cholesterol and apolipoprotein E in Alzheimer's disease. Am J Alzheimers Dis Other Demen 2005, 20:91-96.